NM_002335.4:c.518C>T

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 4P and 5B. PM1PP2PP3BP6BS1

The NM_002335.4(LRP5):​c.518C>T​(p.Thr173Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000253 in 1,614,100 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T173T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00053 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00023 ( 0 hom. )

Consequence

LRP5
NM_002335.4 missense

Scores

1
6
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: -0.110

Publications

9 publications found
Variant links:
Genes affected
LRP5 (HGNC:6697): (LDL receptor related protein 5) This gene encodes a transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis. This protein also acts as a co-receptor with Frizzled protein family members for transducing signals by Wnt proteins and was originally cloned on the basis of its association with type 1 diabetes mellitus in humans. This protein plays a key role in skeletal homeostasis and many bone density related diseases are caused by mutations in this gene. Mutations in this gene also cause familial exudative vitreoretinopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
LRP5 Gene-Disease associations (from GenCC):
  • bone mineral density quantitative trait locus 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • exudative vitreoretinopathy 4
    Inheritance: AD, SD, Unknown Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • osteoporosis-pseudoglioma syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant osteosclerosis, Worth type
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • polycystic liver disease 4 with or without kidney cysts
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal dominant osteopetrosis 1
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • exudative vitreoretinopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hyperostosis corticalis generalisata
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • osteosclerosis-developmental delay-craniosynostosis syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • polycystic liver disease 1
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 13 uncertain in NM_002335.4
PP2
Missense variant in the LRP5 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 71 curated pathogenic missense variants (we use a threshold of 10). The gene has 23 curated benign missense variants. Gene score misZ: 1.6684 (below the threshold of 3.09). Trascript score misZ: 3.6986 (above the threshold of 3.09). GenCC associations: The gene is linked to exudative vitreoretinopathy 4, autosomal dominant osteopetrosis 1, osteoporosis-pseudoglioma syndrome, autosomal dominant osteosclerosis, Worth type, polycystic liver disease 4 with or without kidney cysts, bone mineral density quantitative trait locus 1, osteosclerosis-developmental delay-craniosynostosis syndrome, hyperostosis corticalis generalisata, exudative vitreoretinopathy, polycystic liver disease 1, inherited retinal dystrophy.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.748
BP6
Variant 11-68357679-C-T is Benign according to our data. Variant chr11-68357679-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 669010.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000525 (80/152346) while in subpopulation EAS AF = 0.0027 (14/5182). AF 95% confidence interval is 0.00163. There are 1 homozygotes in GnomAd4. There are 40 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP5NM_002335.4 linkc.518C>T p.Thr173Met missense_variant Exon 3 of 23 ENST00000294304.12 NP_002326.2 O75197

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP5ENST00000294304.12 linkc.518C>T p.Thr173Met missense_variant Exon 3 of 23 1 NM_002335.4 ENSP00000294304.6 O75197
LRP5ENST00000529993.5 linkn.518C>T non_coding_transcript_exon_variant Exon 3 of 23 1 ENSP00000436652.1 E9PHY1

Frequencies

GnomAD3 genomes
AF:
0.000526
AC:
80
AN:
152228
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000844
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00270
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000391
AC:
98
AN:
250806
AF XY:
0.000324
show subpopulations
Gnomad AFR exome
AF:
0.000741
Gnomad AMR exome
AF:
0.000318
Gnomad ASJ exome
AF:
0.00129
Gnomad EAS exome
AF:
0.00125
Gnomad FIN exome
AF:
0.0000465
Gnomad NFE exome
AF:
0.000176
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.000225
AC:
329
AN:
1461754
Hom.:
0
Cov.:
32
AF XY:
0.000224
AC XY:
163
AN XY:
727148
show subpopulations
African (AFR)
AF:
0.000388
AC:
13
AN:
33478
American (AMR)
AF:
0.000425
AC:
19
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.000765
AC:
20
AN:
26130
East Asian (EAS)
AF:
0.000630
AC:
25
AN:
39696
South Asian (SAS)
AF:
0.000510
AC:
44
AN:
86220
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53406
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.000159
AC:
177
AN:
1111962
Other (OTH)
AF:
0.000464
AC:
28
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
19
38
56
75
94
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000525
AC:
80
AN:
152346
Hom.:
1
Cov.:
32
AF XY:
0.000537
AC XY:
40
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.000842
AC:
35
AN:
41578
American (AMR)
AF:
0.000327
AC:
5
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3470
East Asian (EAS)
AF:
0.00270
AC:
14
AN:
5182
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000250
AC:
17
AN:
68036
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000516
Hom.:
0
Bravo
AF:
0.000450
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000371
AC:
45
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000415

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 09, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported previously in association with familial exudative vitreoretinopathy, but the variant was inherited from an unaffected parent (Toomes et al., 2004; Li et al., 2018); Published functional studies demonstrate no damaging effect (Ai et al., 2005); This variant is associated with the following publications: (PMID: 22995991, 15923613, 16252235, 26348019, 15024691, 20340138, 24715757, 30452590) -

Inborn genetic diseases Uncertain:1
Apr 18, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.518C>T (p.T173M) alteration is located in exon 3 (coding exon 3) of the LRP5 gene. This alteration results from a C to T substitution at nucleotide position 518, causing the threonine (T) at amino acid position 173 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

LRP5-related disorder Uncertain:1
Aug 13, 2024
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The LRP5 c.518C>T variant is predicted to result in the amino acid substitution p.Thr173Met. This variant has been reported in two individuals with familial exudative vitreoretinopathy (Toomes et al. 2004. PubMed ID: 15024691; Li et al. 2018. PubMed ID: 30452590), and in an individual with high bone mass (Gregson et al. 2015. PubMed ID: 26348019). However, this variant is reported in 0.15% of alleles in individuals of East Asian descent in gnomAD, including 1 homozygous individual in the newest dataset (https://gnomad.broadinstitute.org/variant/11-68357679-C-T?dataset=gnomad_r4). Therefore, although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Uncertain
0.060
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.58
D
Eigen
Benign
-0.36
Eigen_PC
Benign
-0.45
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.48
T
M_CAP
Uncertain
0.22
D
MetaRNN
Pathogenic
0.75
D
MetaSVM
Uncertain
0.28
D
MutationAssessor
Benign
0.92
L
PhyloP100
-0.11
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.41
N
REVEL
Uncertain
0.61
Sift
Benign
0.11
T
Sift4G
Benign
0.23
T
Polyphen
0.98
D
Vest4
0.71
MVP
0.83
MPC
0.54
ClinPred
0.013
T
GERP RS
1.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.026
gMVP
0.46
Mutation Taster
=30/70
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80358306; hg19: chr11-68125147; API